chronic obstructive pulmonary disease(COPD)
Conditions
Interventions
Experimental group:Baduanjin + conventional treatment
control group:conventional treatment
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. In line with the diagnostic criteria of the 2017 GOLD guidelines, COPD is divided into groups A, B, and C (group A: low risk, few symptoms, group B: low risk, multiple symptoms, group C: high risk, few symptoms) ; 2. In the stable stage of COPD (the stable stage refers to the patients whose symptoms such as cough, expectoration and shortness of breath are stable or mild, and the condition basically returns to the state before the acute exacerbation); 3. Aged 40 to 85 years; 4. Able to complete various assessments required by the research; 5. Those who participated voluntarily and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Suffering from concomitant diseases that can interfere with evaluation, treatment and follow-up (epilepsy, unstable cardiovascular disease, active malignant tumor, severe lower extremity disease, severe neurological impairment, etc.); 2. Have undergone standard pulmonary rehabilitation exercise training or Baduanjin training before joining the group; 3. Those who cannot walk or have severe cognitive impairment; 4. Patients with high risk of falls and balance dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| maximal oxygen uptake;Moderate to high-intensity physical activity;anaerobic threshold; | — |
Secondary
| Measure | Time frame |
|---|---|
| breathlessness measurement using the modified British Medical Research Council;chronic obstructive pulmonary disease assessment test;Activities of daily living;Pulmonary function;Health Status Survey Short Form;resting oxygen uptake; | — |
Countries
China
Contacts
Public ContactCai Qian
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed